Microbes, Clinical trials, Drug Discovery, and Vaccine Development: The Current Perspectives
Because of the frequent emergence of novel microbial species and the re-emergence of genetic variants of hitherto known microbes, the global healthcare system, and human health has been thrown into jeopardy. Also, certain microbes that possess the ability to develop multi-drug resistance (MDR) have...
Guardado en:
Autores principales: | Venkataramana Kandi, Tarun Kumar Suvvari, Sabitha Vadakedath, Vikram Godishala |
---|---|
Formato: | article |
Lenguaje: | EN ID |
Publicado: |
Institute for Researches and Community Services Universitas Muhammadiyah Palangkaraya
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3bf383f07f1444fe90c3cc054d9d84e5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Potential Use of Aptamers in The Process of Drug Development
por: Tooba Gholikhani, et al.
Publicado: (2021) -
Bioassay Guided Fractionation of Marine Streptomyces sp. GMY01 and Antiplasmodial Assay using Microscopic and Flow Cytometry Method
por: Ema Damayanti, et al.
Publicado: (2020) -
Natural Bioactive Cyclopeptides from Microbes as Promising Anticancer Drug Leads: A Mini-review
por: Linda Sukmarini
Publicado: (2021) -
Discovery of a Potent Candidate for RET-Specific Non-Small-Cell Lung Cancer—A Combined In Silico and In Vitro Strategy
por: Priyanka Ramesh, et al.
Publicado: (2021) - Drug discoveries & therapeutics